Stem Cell Equipment
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Viral Vectors Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vectors Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Retroviral Vectors
1.2.3 Lentiviral Vectors
1.2.4 Adenoviral Vectors
1.2.5 Herpes Simplex Virus Vectors
1.2.6 Chimeric Viral Vectors
1.2.7 Others
1.3 Market by Application
1.3.1 Global Viral Vectors Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Cancers
1.3.3 Inherited Disorders
1.3.4 Viral Infections
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Viral Vectors Market Perspective (2017-2028)
2.2 Viral Vectors Growth Trends by Region
2.2.1 Viral Vectors Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Viral Vectors Historic Market Size by Region (2017-2022)
2.2.3 Viral Vectors Forecasted Market Size by Region (2023-2028)
2.3 Viral Vectors Market Dynamics
2.3.1 Viral Vectors Industry Trends
2.3.2 Viral Vectors Market Drivers
2.3.3 Viral Vectors Market Challenges
2.3.4 Viral Vectors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vectors Players by Revenue
3.1.1 Global Top Viral Vectors Players by Revenue (2017-2022)
3.1.2 Global Viral Vectors Revenue Market Share by Players (2017-2022)
3.2 Global Viral Vectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Vectors Revenue
3.4 Global Viral Vectors Market Concentration Ratio
3.4.1 Global Viral Vectors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vectors Revenue in 2021
3.5 Viral Vectors Key Players Head office and Area Served
3.6 Key Players Viral Vectors Product Solution and Service
3.7 Date of Enter into Viral Vectors Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vectors Breakdown Data by Type
4.1 Global Viral Vectors Historic Market Size by Type (2017-2022)
4.2 Global Viral Vectors Forecasted Market Size by Type (2023-2028)
5 Viral Vectors Breakdown Data by Application
5.1 Global Viral Vectors Historic Market Size by Application (2017-2022)
5.2 Global Viral Vectors Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Viral Vectors Market Size (2017-2028)
6.2 North America Viral Vectors Market Size by Country (2017-2022)
6.3 North America Viral Vectors Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Viral Vectors Market Size (2017-2028)
7.2 Europe Viral Vectors Market Size by Country (2017-2022)
7.3 Europe Viral Vectors Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Vectors Market Size (2017-2028)
8.2 Asia-Pacific Viral Vectors Market Size by Country (2017-2022)
8.3 Asia-Pacific Viral Vectors Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Viral Vectors Market Size (2017-2028)
9.2 Latin America Viral Vectors Market Size by Country (2017-2022)
9.3 Latin America Viral Vectors Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vectors Market Size (2017-2028)
10.2 Middle East & Africa Viral Vectors Market Size by Country (2017-2022)
10.3 Middle East & Africa Viral Vectors Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 BioReliance
11.1.1 BioReliance Company Detail
11.1.2 BioReliance Business Overview
11.1.3 BioReliance Viral Vectors Introduction
11.1.4 BioReliance Revenue in Viral Vectors Business (2017-2022)
11.1.5 BioReliance Recent Development
11.2 Cobra Biologics
11.2.1 Cobra Biologics Company Detail
11.2.2 Cobra Biologics Business Overview
11.2.3 Cobra Biologics Viral Vectors Introduction
11.2.4 Cobra Biologics Revenue in Viral Vectors Business (2017-2022)
11.2.5 Cobra Biologics Recent Development
11.3 Oxford BioMedica
11.3.1 Oxford BioMedica Company Detail
11.3.2 Oxford BioMedica Business Overview
11.3.3 Oxford BioMedica Viral Vectors Introduction
11.3.4 Oxford BioMedica Revenue in Viral Vectors Business (2017-2022)
11.3.5 Oxford BioMedica Recent Development
11.4 UniQure
11.4.1 UniQure Company Detail
11.4.2 UniQure Business Overview
11.4.3 UniQure Viral Vectors Introduction
11.4.4 UniQure Revenue in Viral Vectors Business (2017-2022)
11.4.5 UniQure Recent Development
11.5 FinVector
11.5.1 FinVector Company Detail
11.5.2 FinVector Business Overview
11.5.3 FinVector Viral Vectors Introduction
11.5.4 FinVector Revenue in Viral Vectors Business (2017-2022)
11.5.5 FinVector Recent Development
11.6 MolMed
11.6.1 MolMed Company Detail
11.6.2 MolMed Business Overview
11.6.3 MolMed Viral Vectors Introduction
11.6.4 MolMed Revenue in Viral Vectors Business (2017-2022)
11.6.5 MolMed Recent Development
11.7 MassBiologics
11.7.1 MassBiologics Company Detail
11.7.2 MassBiologics Business Overview
11.7.3 MassBiologics Viral Vectors Introduction
11.7.4 MassBiologics Revenue in Viral Vectors Business (2017-2022)
11.7.5 MassBiologics Recent Development
11.8 Richter-Helm
11.8.1 Richter-Helm Company Detail
11.8.2 Richter-Helm Business Overview
11.8.3 Richter-Helm Viral Vectors Introduction
11.8.4 Richter-Helm Revenue in Viral Vectors Business (2017-2022)
11.8.5 Richter-Helm Recent Development
11.9 FUJIFILM Diosynth Biotechnologies
11.9.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors Introduction
11.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors Business (2017-2022)
11.9.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.10 Lonza
11.10.1 Lonza Company Detail
11.10.2 Lonza Business Overview
11.10.3 Lonza Viral Vectors Introduction
11.10.4 Lonza Revenue in Viral Vectors Business (2017-2022)
11.10.5 Lonza Recent Development
11.11 Aldevron
11.11.1 Aldevron Company Detail
11.11.2 Aldevron Business Overview
11.11.3 Aldevron Viral Vectors Introduction
11.11.4 Aldevron Revenue in Viral Vectors Business (2017-2022)
11.11.5 Aldevron Recent Development
11.12 Eurogentec
11.12.1 Eurogentec Company Detail
11.12.2 Eurogentec Business Overview
11.12.3 Eurogentec Viral Vectors Introduction
11.12.4 Eurogentec Revenue in Viral Vectors Business (2017-2022)
11.12.5 Eurogentec Recent Development
11.13 Cell and Gene Therapy Catapult
11.13.1 Cell and Gene Therapy Catapult Company Detail
11.13.2 Cell and Gene Therapy Catapult Business Overview
11.13.3 Cell and Gene Therapy Catapult Viral Vectors Introduction
11.13.4 Cell and Gene Therapy Catapult Revenue in Viral Vectors Business (2017-2022)
11.13.5 Cell and Gene Therapy Catapult Recent Development
11.14 Biovian
11.14.1 Biovian Company Detail
11.14.2 Biovian Business Overview
11.14.3 Biovian Viral Vectors Introduction
11.14.4 Biovian Revenue in Viral Vectors Business (2017-2022)
11.14.5 Biovian Recent Development
11.15 Thermo Fisher Scientific (Brammer Bio)
11.15.1 Thermo Fisher Scientific (Brammer Bio) Company Detail
11.15.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
11.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors Introduction
11.15.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors Business (2017-2022)
11.15.5 Thermo Fisher Scientific (Brammer Bio) Recent Development
11.16 VGXI
11.16.1 VGXI Company Detail
11.16.2 VGXI Business Overview
11.16.3 VGXI Viral Vectors Introduction
11.16.4 VGXI Revenue in Viral Vectors Business (2017-2022)
11.16.5 VGXI Recent Development
11.17 PlasmidFactory
11.17.1 PlasmidFactory Company Detail
11.17.2 PlasmidFactory Business Overview
11.17.3 PlasmidFactory Viral Vectors Introduction
11.17.4 PlasmidFactory Revenue in Viral Vectors Business (2017-2022)
11.17.5 PlasmidFactory Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Viral Vectors Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Retroviral Vectors
Table 3. Key Players of Lentiviral Vectors
Table 4. Key Players of Adenoviral Vectors
Table 5. Key Players of Herpes Simplex Virus Vectors
Table 6. Key Players of Chimeric Viral Vectors
Table 7. Key Players of Others
Table 8. Global Viral Vectors Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Viral Vectors Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Viral Vectors Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global Viral Vectors Market Share by Region (2017-2022)
Table 12. Global Viral Vectors Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global Viral Vectors Market Share by Region (2023-2028)
Table 14. Viral Vectors Market Trends
Table 15. Viral Vectors Market Drivers
Table 16. Viral Vectors Market Challenges
Table 17. Viral Vectors Market Restraints
Table 18. Global Viral Vectors Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global Viral Vectors Market Share by Players (2017-2022)
Table 20. Global Top Viral Vectors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors as of 2021)
Table 21. Ranking of Global Top Viral Vectors Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by Viral Vectors Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Viral Vectors Product Solution and Service
Table 25. Date of Enter into Viral Vectors Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Viral Vectors Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global Viral Vectors Revenue Market Share by Type (2017-2022)
Table 29. Global Viral Vectors Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global Viral Vectors Revenue Market Share by Type (2023-2028)
Table 31. Global Viral Vectors Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global Viral Vectors Revenue Market Share by Application (2017-2022)
Table 33. Global Viral Vectors Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global Viral Vectors Revenue Market Share by Application (2023-2028)
Table 35. North America Viral Vectors Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Viral Vectors Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Viral Vectors Market Size by Country (2017-2022) & (US$ Million)
Table 38. Europe Viral Vectors Market Size by Country (2023-2028) & (US$ Million)
Table 39. Asia-Pacific Viral Vectors Market Size by Region (2017-2022) & (US$ Million)
Table 40. Asia-Pacific Viral Vectors Market Size by Region (2023-2028) & (US$ Million)
Table 41. Latin America Viral Vectors Market Size by Country (2017-2022) & (US$ Million)
Table 42. Latin America Viral Vectors Market Size by Country (2023-2028) & (US$ Million)
Table 43. Middle East & Africa Viral Vectors Market Size by Country (2017-2022) & (US$ Million)
Table 44. Middle East & Africa Viral Vectors Market Size by Country (2023-2028) & (US$ Million)
Table 45. BioReliance Company Detail
Table 46. BioReliance Business Overview
Table 47. BioReliance Viral Vectors Product
Table 48. BioReliance Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
Table 49. BioReliance Recent Development
Table 50. Cobra Biologics Company Detail
Table 51. Cobra Biologics Business Overview
Table 52. Cobra Biologics Viral Vectors Product
Table 53. Cobra Biologics Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
Table 54. Cobra Biologics Recent Development
Table 55. Oxford BioMedica Company Detail
Table 56. Oxford BioMedica Business Overview
Table 57. Oxford BioMedica Viral Vectors Product
Table 58. Oxford BioMedica Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
Table 59. Oxford BioMedica Recent Development
Table 60. UniQure Company Detail
Table 61. UniQure Business Overview
Table 62. UniQure Viral Vectors Product
Table 63. UniQure Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
Table 64. UniQure Recent Development
Table 65. FinVector Company Detail
Table 66. FinVector Business Overview
Table 67. FinVector Viral Vectors Product
Table 68. FinVector Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
Table 69. FinVector Recent Development
Table 70. MolMed Company Detail
Table 71. MolMed Business Overview
Table 72. MolMed Viral Vectors Product
Table 73. MolMed Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
Table 74. MolMed Recent Development
Table 75. MassBiologics Company Detail
Table 76. MassBiologics Business Overview
Table 77. MassBiologics Viral Vectors Product
Table 78. MassBiologics Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
Table 79. MassBiologics Recent Development
Table 80. Richter-Helm Company Detail
Table 81. Richter-Helm Business Overview
Table 82. Richter-Helm Viral Vectors Product
Table 83. Richter-Helm Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
Table 84. Richter-Helm Recent Development
Table 85. FUJIFILM Diosynth Biotechnologies Company Detail
Table 86. FUJIFILM Diosynth Biotechnologies Business Overview
Table 87. FUJIFILM Diosynth Biotechnologies Viral Vectors Product
Table 88. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
Table 89. FUJIFILM Diosynth Biotechnologies Recent Development
Table 90. Lonza Company Detail
Table 91. Lonza Business Overview
Table 92. Lonza Viral Vectors Product
Table 93. Lonza Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
Table 94. Lonza Recent Development
Table 95. Aldevron Company Detail
Table 96. Aldevron Business Overview
Table 97. Aldevron Viral VectorsProduct
Table 98. Aldevron Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
Table 99. Aldevron Recent Development
Table 100. Eurogentec Company Detail
Table 101. Eurogentec Business Overview
Table 102. Eurogentec Viral VectorsProduct
Table 103. Eurogentec Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
Table 104. Eurogentec Recent Development
Table 105. Cell and Gene Therapy Catapult Company Detail
Table 106. Cell and Gene Therapy Catapult Business Overview
Table 107. Cell and Gene Therapy Catapult Viral VectorsProduct
Table 108. Cell and Gene Therapy Catapult Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
Table 109. Cell and Gene Therapy Catapult Recent Development
Table 110. Biovian Company Detail
Table 111. Biovian Business Overview
Table 112. Biovian Viral VectorsProduct
Table 113. Biovian Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
Table 114. Biovian Recent Development
Table 115. Thermo Fisher Scientific (Brammer Bio) Company Detail
Table 116. Thermo Fisher Scientific (Brammer Bio) Business Overview
Table 117. Thermo Fisher Scientific (Brammer Bio) Viral VectorsProduct
Table 118. Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
Table 119. Thermo Fisher Scientific (Brammer Bio) Recent Development
Table 120. VGXI Company Detail
Table 121. VGXI Business Overview
Table 122. VGXI Viral VectorsProduct
Table 123. VGXI Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
Table 124. VGXI Recent Development
Table 125. PlasmidFactory Company Detail
Table 126. PlasmidFactory Business Overview
Table 127. PlasmidFactory Viral VectorsProduct
Table 128. PlasmidFactory Revenue in Viral Vectors Business (2017-2022) & (US$ Million)
Table 129. PlasmidFactory Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Vectors Market Share by Type: 2021 VS 2028
Figure 2. Retroviral Vectors Features
Figure 3. Lentiviral Vectors Features
Figure 4. Adenoviral Vectors Features
Figure 5. Herpes Simplex Virus Vectors Features
Figure 6. Chimeric Viral Vectors Features
Figure 7. Others Features
Figure 8. Global Viral Vectors Market Share by Application in 2021 & 2028
Figure 9. Cancers Case Studies
Figure 10. Inherited Disorders Case Studies
Figure 11. Viral Infections Case Studies
Figure 12. Others Case Studies
Figure 13. Viral Vectors Report Years Considered
Figure 14. Global Viral Vectors Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Viral Vectors Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Viral Vectors Market Share by Region: 2021 VS 2028
Figure 17. Global Viral Vectors Market Share by Players in 2021
Figure 18. Global Top Viral Vectors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Viral Vectors Revenue in 2021
Figure 20. North America Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. North America Viral Vectors Market Share by Country (2017-2028)
Figure 22. United States Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Viral Vectors Market Share by Country (2017-2028)
Figure 26. Germany Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Viral Vectors Market Share by Region (2017-2028)
Figure 34. China Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Viral Vectors Market Share by Country (2017-2028)
Figure 42. Mexico Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Brazil Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Middle East & Africa Viral Vectors Market Share by Country (2017-2028)
Figure 46. Turkey Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Saudi Arabia Viral Vectors Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. BioReliance Revenue Growth Rate in Viral Vectors Business (2017-2022)
Figure 49. Cobra Biologics Revenue Growth Rate in Viral Vectors Business (2017-2022)
Figure 50. Oxford BioMedica Revenue Growth Rate in Viral Vectors Business (2017-2022)
Figure 51. UniQure Revenue Growth Rate in Viral Vectors Business (2017-2022)
Figure 52. FinVector Revenue Growth Rate in Viral Vectors Business (2017-2022)
Figure 53. MolMed Revenue Growth Rate in Viral Vectors Business (2017-2022)
Figure 54. MassBiologics Revenue Growth Rate in Viral Vectors Business (2017-2022)
Figure 55. Richter-Helm Revenue Growth Rate in Viral Vectors Business (2017-2022)
Figure 56. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vectors Business (2017-2022)
Figure 57. Lonza Revenue Growth Rate in Viral Vectors Business (2017-2022)
Figure 58. Aldevron Revenue Growth Rate in Viral Vectors Business (2017-2022)
Figure 59. Eurogentec Revenue Growth Rate in Viral Vectors Business (2017-2022)
Figure 60. Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vectors Business (2017-2022)
Figure 61. Biovian Revenue Growth Rate in Viral Vectors Business (2017-2022)
Figure 62. Thermo Fisher Scientific (Brammer Bio) Revenue Growth Rate in Viral Vectors Business (2017-2022)
Figure 63. VGXI Revenue Growth Rate in Viral Vectors Business (2017-2022)
Figure 64. PlasmidFactory Revenue Growth Rate in Viral Vectors Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
BioReliance Cobra Biologics Oxford BioMedica UniQure FinVector MolMed MassBiologics Richter-Helm FUJIFILM Diosynth Biotechnologies Lonza Aldevron Eurogentec Cell and Gene Therapy Catapult Biovian Thermo Fisher Scientific (Brammer Bio) VGXI PlasmidFactory